OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types...
12,245 insider purchases on record · latest filing 2026-03-20.
Insiders have also filed 42 sale transactions at OPK.